SEC SCHEDULE 13G

Company

CRISPR Therapeutics AG

Filed

September 10, 2020

Accession Number

0001562230-20-000075

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →